Compared with control group, transfected mice stably expressing IL-37 showed significantly reduced tumor growth rate, microvessel density, and expression levels of VGEF and CD34, and IL-37 treatment also significantly inhibited the growth and angiogenesis of human umbilical vein endothelial cells (HUVECs) [23]. This evidence concerns the gene IL37 and neoplasm.